• The CUL4 ubiquitin ligases target HOXB4 for ubiquitination and degradation.
Introduction
Hematopoietic stem cells (HSCs) are pluripotent, asymetrically self-renewing cells that give rise to all mature blood cells through successive rounds of differentiation. The signals that govern the self-renewal process have been intensively pursued as it may be possible to promote HSC expansion by transiently enforcing proliferation pathways or blocking differentiation cues, which would be highly desirable as a means to augment the number of HSCs for transplantation.
Currently, HSC transplantation is used to treat hematological diseases, such as leukemia and bone marrow failure. HSCs are derived from three sources: umbilical cord blood (UCB), adult bone marrow, and peripheral blood following treatment with recombinant human granulocyte colony-stimulating factor (G-CSF), a cytokine that mobilizes HSCs from the bone marrow and allows for their harvest through peripheral blood apheresis. Ex vivo expansion of HSCs from these sources would improve transplantation outcomes and help meet the demand for stem cell transplants by permitting the use of samples of limited quantity (e.g., cord blood) or with low total numbers of HSCs (e.g., poor HSC mobilizers).
Ex vivo expansion of HSCs and progenitor cells has been the subject of considerable investigation with the use of combinations of hematopoietic growth factors 1 , synthetic small molecular weight compounds identified by high-throughput screening 2 , and the use of supportive bone marrow stroma 3, 4 . In human studies, adult HSCs can undergo repeated rounds of asymmetric self-renewal with maintenance of the stem cell pool but with little or no expansion.
In contrast, fetal and neonatal stem cells can be maintained in culture for 2-3 months with absolute increases in the number of HSCs. Ex vivo expansions of 7-9 fold in SCID-repopulating HSCs have been reported over 12-14 days in a number of studies 1, 3, 5 .
For personal use only. on May 3, 2017 . by guest www.bloodjournal.org From 4 Homeobox (HOX) genes encode transcription factors that regulate patterning during embryonic development, and hematopoiesis both pre-and post-natally. In early development, HOX gene expression is both temporally and spatially regulated, as reflected by the sequential order of transcription with respect to their 3' to 5' chromosomal position. However, the spatiotemporal regulation of HOX gene expression is not observed in hematopoiesis, but instead assumes a complex, overlapping expression pattern that is not lineage-specific. Northern blotting analysis revealed that most HOX genes, excluding HOXD, are highly expressed in HSCs and progenitor cells, and are generally downregulated as cells terminally differentiate into mature, lineage-specific blood cells 6 . To date, the mechanisms underlying transcriptional regulation of HOX genes during hematopoiesis remain largely unknown.
The identification of HOX genes that are highly expressed in CD34 + HSCs and early progenitors led to several overexpression studies that revealed the effects of specific HOX genes on HSC proliferation. In particular, sustained HOXB4 expression by retroviral transduction promoted the selective expansion of murine HSCs in cell culture and following bone marrow transplantation 7 . Moreover, the enhanced proliferation of HOXB4-transduced HSCs was not leukemogenic in transplanted mice 8, 9 , indicating that enforced HOXB4 expression did not alter HSC differentiation. In marked contrast, the ectopic expression of other HOX genes highly expressed in HSCs, such as HOXA9 and HOXB7, did result in myeloid leukemia 10, 11 .
Comparison of the effects of HOXB4 overexpression in different species further revealed species-specific variations in the magnitude of HOXB4-induced HSC proliferation, with more modest effects observed in cells from humans and baboons than mice and dogs 12 . Thus, the effect of ectopic HOXB4 expression in promoting human HSC proliferation is likely more equivocal than the robust outcome obtained in murine HSCs. Follow-up studies revealed the development of myeloid leukemia in large mammals two years post-transplantation with HSCs expressing retrovirally-transduced HOXB4 12 , highlighting the risks of such genetic manipulation. While the molecular basis underlying the observed leukemogenesis appears to be HOXB4-dependent, integration of a transgene at chromosomal "hotspots" may also lead to the activation of adjacent oncogenes, and is believed to contribute to gene therapy-associated malignancy [13] [14] [15] . Therefore, a transient, non-viral delivery method to augment HOXB4 levels in HSCs is necessary for potential human therapeutic applications. To that end, direct protein transduction has been established as an alternative method of introducing HOXB4 into HSCs 16, 17 . We previously studied the post-translational regulation of homeodomain-containing proteins by the CUL4A ubiquitin ligase, and determined that CUL4A targets HOXA9, a transcription factor that promotes HSC proliferation, for ubiquitination and proteosome-mediated degradation 21 . Additionally, the AML-associated Nup98-HOXA9 fusion protein is resistant to CUL4A-mediated ubiquitination, and the resulting protein stabilization may contribute to its potent leukemogenic activity 22 . In this study, we showed that representative members of multiple HOX paralogous groups, including HOXB4, are subjected to ubiquitination and subsequent 
Methods

Cell Cultures, Plasmids and Protein Extracts
Steady-state levels of epitope-tagged HOX proteins in response to increasing levels of MYC-CUL4A were determined following transfection of 293T cells with 1 μg of the indicated HOX plasmids (lanes 1-4) and 1, 3, or 9 μg MYC-CUL4A (lane 2-4). All DNA amounts were normalized with vector DNA, and protein levels were detected using standard Western blotting techniques with anti-MYC (Roche), anti-HA (Covance) and anti-β-actin (Santa Cruz) antibodies.
To measure the effect of CUL4A silencing on HOXB4 half-life, HeLa cells were transiently transfected with 6 μg MYC-HOXB4 and 6 μg shCONTROL or 6 μg shCUL4A.
Pulse-chase of transfected HeLa cells was performed as previously described 23 . The half-lives of (lanes 4 and 8) MYC-CUL4A. All DNA amounts were normalized with vector DNA, and protein levels were detected using standard Western blotting techniques.
Wild-type and mutant HA-HOXB4 were retrovirally transduced into 32D cells as previously described 21 and sorted by GFP expression. The MIGRI retroviral vector alone Replacement (Invitrogen), 1% penicillin/streptomycin (Mediatech) and 2 ng/mL murine IL-3 (Miltenyi Biotech). Cells were passaged every three days, and counted daily. HOXB4 half-life was measured following addition of 50 μM cycloheximide (final concentration). Samples were harvested at the indicated times, and HA-HOXB4 levels were determined by Western blotting.
In vitro HSC assays
To express recombinant protein, wild-type and mutant HOXB4 were subcloned into the pTAT-HA expression vector (generous gift from Dr. Steven Dowdy). Recombinant protein was purified as previously described 18 , and desalted using PD-10 columns (GE Healthcare Life 
Results
CUL4A mediates ubiquitination of HOXB4
We previously determined that HOXA9 is specifically targeted for ubiquitination and degradation by CUL4A 21 , and observed that members of the HOX4 family also interacted with CUL4A by yeast two-hydrid assay (Zhang and Zhou, unpublished) . Due to its well-established ability to promote HSC self-renewal, we first evaluated whether HOXB4 is subject to CUL4A-
The steady-state levels of MYC-tagged HOXB4 decreased corresponding to increasing levels of MYC-CUL4A (Fig. 1A) . Conversely, knockdown of CUL4A by shRNA prolonged the half-life of HOXB4 (Fig. 1B, S1 ). Following the addition of MG132, we observed that HOXB4 is polyubiquitinated, and enforced expression of dominant-negative CUL4A (previously described in 23 ) dramatically reduced ubiquitination of HOXB4 in a dose-dependent manner (Fig. 1C ).
CUL4A and CUL4B are 82% identical, and target similar substrates for ubiquitination and degradation 24, 25 . To determine the role of CUL4A and CUL4B on HOXB4 stability in hematopoietic progenitor cells, we compared the endogenous HOXB4 protein levels in hematopoietic stem and progenitor cells derived from Cul4a-and Cul4b-null mice versus their wild-type littermates, and observed that the deletion of either Cul4a or Cul4b resulted in the increased accumulation of HOXB4 protein levels (Fig. 1D) . Taken together, these results indicate a role for both CUL4A and CUL4B as regulators of HOXB4 stability. Our studies hereafter utilized CUL4A as the representative CUL4 E3 ligase to investigate the biochemical mechanisms and functional implications of this E3 family in orchestrating the ubiquitination and degradation of HOXB4.
With the evidence that CUL4A targets both HOXA9 and HOXB4 for ubiquitination, we next sought to determine whether other HOX proteins in the Class I homeodomain family are subject to CUL4A-mediated degradation. Indeed, the steady-state levels of representative HOX paralogous group proteins, including HOXA1, A2, B7, B8, A11 and A13, also decreased corresponding to increasing levels of MYC-CUL4A (Fig. 2) , while the HOX co-factor Meis1
was not subjected to CUL4A-mediated degradation (Fig. S2) . Thus, the post-translational
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regulation of HOX protein stability by the CUL4A ubiquitin ligase may be mediated through a conserved mechanism, such as recognition of a common HOX protein domain.
CUL4A-specific HOXB4 degron
Our previous studies on HOXA9 indicated that the homeodomain, which is required for DNA-binding activity of HOX proteins, is also necessary for CUL4A-mediated HOXA9 turnover 21 . A sequence alignment of the highly conserved homeodomain among all HOX proteins revealed a conserved LEXE motif in helix I that is not involved in DNA binding (Fig.   3A ) 26 . Given our observation that several HOX paralogous groups are post-translationally regulated by CUL4A, we examined whether the conserved LEXE motif may comprise the CUL4A-dependent degron, or the substrate sequence that directs its recognition by a specific ubiquitin ligase for degradation. While mutation of the first two residues of the LEXE motif prolonged the HOXB4 protein half-life compared to wild-type protein, the triple mutant, HOXB4(M3), dramatically extended HOXB4 protein stability (Fig. 3B, C) . Accordingly, we designated the triple mutant as degradation-resistant HOXB4 or HOXB4(m).
To determine if the LEXE motif in the context of its native tertiary structure is required to target proteins for CUL4A-mediated degradation, wild-type or mutant HOXB4 homeodomain was fused to eGFP, a long-lived protein that is not a native CUL4A substrate. The fusion of eGFP to the wild-type HOXB4 homeodomain conferred sensitivity to CUL4A-mediated degradation, while the eGFP-HOXB4 mutant homeodomain protein remained resistant to increasing levels of CUL4A (Fig. 3D ). We conclude from these studies that the LEXE motif within helix I of the HOXB4 homeodomain constitutes a transferable signal that is both necessary and sufficient to mediate CUL4A-dependent degradation.
For
HOXB4(m) enhances 32D proliferation
To determine whether HOXB4 degradation by CUL4A impacts the proliferation potential of hematopoietic cells, we retrovirally transduced HOXB4 or HOXB4(m) into the 32D murine myeloid progenitor cell line and observed that steady-state levels of HOXB4(m) were higher than wild-type HOXB4, while the mRNA levels were comparable (Fig. 4A, S3) . Next, we compared their growth in serum-free medium and found that ectopic expression of either wildtype or degradation-resistant HOXB4 resulted in a distinct growth advantage over control cells.
Remarkably, 32D cells expressing HOXB4(m) showed a further 10-fold increase in cell number compared to wild-type HOXB4-transduced cells after 15 days in culture, representing a 10,000-fold increase compared to 32D cells transduced with vector alone (Fig. 4B) . Correspondingly, the half-life of HOXB4(m) was substantially longer than wild-type HOXB4 (Fig. 4C) , indicating that the enhanced protein stability of HOXB4(m) contributes to the growth advantage of 32D myeloid progenitors.
HOXB4(m) maintains HSC potential
HSCs derived from peripheral blood are more readily available and abundant than those (Fig. S4) , consistent with the typical punctate distribution of transduced TAT-fusion proteins 28 . Diffused nuclear localization was also observed, especially for TAT-HA-HOXB4(m) (Fig. S4) . The transcriptional activity of putative HOXB4 target genes was similar following the addition of wild-type or degradation-resistant HOXB4 protein (Fig.   S5 ). As shown in Fig. 5B -C, the total number of both myeloid and erythroid colony-forming cells increased >10-fold with the addition of HOXB4(m) compared to wild-type HOXB4 protein.
Moreover, myeloid (CFU-GM) and erythroid burst-forming cells (BFU-E) grown in the presence of HOXB4(m) were significantly larger and more frequent (Fig. 5B-C) . In contrast, UCB CD34 + cells responded similarly following the addition of recombinant wild-type or degradationresistant HOXB4 protein (Fig. S6) further highlighting the effect of HOXB4(m) in G-CSFmobilized adult HSCs. We also performed limiting dilution cobblestone area-forming colony (CAFC) assays to quantify the number of HSCs in G-CSF-mobilized adult CD34 + cells that were 
Discussion
Previous studies have demonstrated the ability of HOXB4 to expand HSCs, but a practical method of delivering HOXB4 had yet to be devised that ensures safety and pharmaceutical compatibility. Although the ectopic expression of HOXB4 following retroviral transduction was not reported to induce leukemia in mice, follow-up studies have since identified the truncation of the HOXB4 N-terminus, but the exact mechanism that accounts for this effect is unknown 18 . In this study, we have determined the biochemical mechanism for the posttranslational regulation of HOXB4 that can be exploited to advance the field of ex vivo HSC expansion. We previously demonstrated that HOXA9 was targeted for CUL4A-mediated degradation, and found that the degradation signal resided in the homeodomain 21 . Here, we determined that CUL4A is responsible for the proteasome-mediated degradation of multiple HOX proteins, and identified a conserved homeodomain motif as a significant determinant for CUL4A-directed activity. Fusion of the HOXB4 homeodomain to a non-native CUL4A substrate was sufficient to target the protein for CUL4A-mediated degradation, indicating that the HOXB4 homeodomain contains a bona fide CUL4A degron. Future studies may exploit this finding to direct the degradation of proteins in a CUL4A-dependent manner.
Constitutive Cul4a-and Cul4b-knockout mice exhibited no defects in hematopoiesis 24, 25 .
Here, we showed that the deletion of either CUL4 family members led to increased accumulation 
